Home > Boards > US Listed > Biotechs > iBio, Inc. (IBIO)

the Special Sauce Right Across the Street - $iBio

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
guay Member Profile
 
Followed By 32
Posts 3,506
Boards Moderated 0
Alias Born 08/04/09
160x600 placeholder
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 10/27/2020 5:01:01 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 10/23/2020 5:21:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2020 4:06:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/16/2020 4:06:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2020 6:10:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2020 6:10:08 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2020 6:09:10 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/16/2020 6:08:32 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/16/2020 6:07:29 AM
Accomplished Financial Executive, Gary Sender, Joins iBio’s Board of Directors GlobeNewswire Inc. - 10/15/2020 4:05:10 PM
iBio Announces Appointment of Dr. Alexandra Kropotova to Board of Directors GlobeNewswire Inc. - 10/15/2020 7:30:10 AM
iBio Announces Appointment of Dr. Linda Armstrong to Board of Directors GlobeNewswire Inc. - 10/14/2020 4:05:10 PM
Annual Report (10-k) Edgar (US Regulatory) - 10/13/2020 5:19:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/13/2020 4:28:18 PM
iBio Announces Financial Results for Fiscal Year Ended June 30, 2020 GlobeNewswire Inc. - 10/13/2020 4:05:10 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 10/13/2020 7:00:49 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2020 4:31:28 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/5/2020 8:32:16 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/5/2020 8:01:44 AM
iBio Regains Compliance with NYSE American Continued Listing Standards GlobeNewswire Inc. - 10/5/2020 7:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/2/2020 7:31:01 AM
iBio Enters into Agreement with Safi Biosolutions to Develop Growth Factors and Cytokines Using the FastPharming® System GlobeNewswire Inc. - 10/2/2020 7:00:10 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 9/28/2020 6:07:20 AM
iBio to Advance COVID-19 LicKM-Subunit Vaccine Candidate, IBIO-201 GlobeNewswire Inc. - 9/9/2020 8:45:10 AM
iBio and Planet Biotechnology Enter into Exclusive Worldwide License Agreement for the Development of a COVID-19 Therapeutic GlobeNewswire Inc. - 8/28/2020 7:15:10 AM
guay   Saturday, 08/15/20 06:03:34 AM
Re: None
Post # of 25162 
the Special Sauce Right Across the Street - $iBio
Quote:
Okay wake up... FujiFilm Diosynth Biotechnologies has been selected to manufacture Novavax.

In our PR on April 9th Casper says this

“Combining iBio’s VLP antigen with an IDRI adjuvant provides for promising safety and efficacy characteristics, and importantly, the ready ability to scale-up manufacturing to help meet the projected global demand for a suitable vaccine.”

THEY ARE RIGHT ACROSS THE STREET.

Okay.

CASPER TALKS ADJUVANTS in the Novavax Article. On AUGUST 6th The Novavax vaccine requires an immune-boosting ingredient called an adjuvant to be effective.

npr.org/sections/health-shot 2020/08/06/899813217/the-special-sauce-that-makes-some-vaccines-work

TOM TWEETS THE SPECIAL SAUCE. On AUGUST 10th

WE ARE MANUFACTURING AND WORKING OUR ASSES OFF.

MANUFACTURING ADJUVANTS HELPING OUT ACROSS THE STREET

Source: https://stocktwits.com/ibio_bagholder23/message/236712099


https://www.wksu.org/post/special-sauce-makes-some-vaccines-work





Company Overview
iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.
The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines.

#iBio $iBio iBio



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences